Related Experiment Video
Updated: Oct 2, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes
S Finch1, E Joseloff, T Bowden
1Department of Radiation Oncology, University of Arizona, Health Sciences Center, Rm. 4993, Arizona Cancer Center, 1515 N. Campbell, Tucson, AR 85724, USA.
Objective:
Previously we have shown that a malignant mouse keratinocyte cell line, 10Gy5, has elevated AP-1 transactivation and reduced JunB protein levels compared to its parental benign cell line, 308, and that the tumorigenicity in the 10Gy5 cells could be blocked by a dominant negative c-Jun mutant protein. We wished to determine whether the change in JunB protein levels could account for the elevated AP-1 activity and whether re-expression of JunB in malignant 10Gy5 cells altered their proliferative capacity.
Design:
In the current study, we reduced JunB expression in benign 308 cells with antisense oligonucleotides and increased JunB expression in malignant 10Gy5 cells by stable transfection of a JunB expression vector.
Results:
Increased AP-1 activity was detected after treatment of the benign 308 cell line with JunB antisense oligonucleotides that reduced JunB protein levels. Stably JunB-transfected clones of malignant 10Gy5 cells showed decreased AP-1 activity, slowed in vitro cell proliferation and reduced tumor growth when xenografted to athymic nude mice.
Conclusion:
These findings suggest that expression of JunB protein has a negative effect on malignant tumor cell proliferation in part through its ability to inhibit AP-1 transactivation.
Insights
JunB protein levels influence cancer cell activity. Lowering JunB increased AP-1 activity in benign cells, while restoring JunB in malignant cells reduced proliferation and tumor growth, suggesting JunB inhibits AP-1 transactivation.
Area of Science:
- Molecular biology
- Cancer research
- Cell biology
Background:
- Malignant keratinocyte cell lines exhibit elevated AP-1 transactivation and reduced JunB protein levels compared to benign counterparts.
- Tumorigenicity in malignant cells can be inhibited by dominant-negative c-Jun mutants.
Purpose of the Study:
- To investigate if JunB protein levels mediate elevated AP-1 activity.
- To determine if re-expressing JunB in malignant cells affects their proliferative capacity.
Main Methods:
- JunB expression was reduced in benign cells using antisense oligonucleotides.
- JunB expression was increased in malignant cells via stable transfection with a JunB expression vector.
Main Results:
- Reducing JunB in benign cells increased AP-1 activity.
- JunB re-expression in malignant cells decreased AP-1 activity, slowed proliferation, and reduced tumor growth in vivo.
Conclusions:
- JunB protein expression negatively impacts malignant tumor cell proliferation.
- JunB's inhibitory effect on AP-1 transactivation contributes to its anti-proliferative role.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

